GPC-3 in hepatocellular carcinoma: current perspectives

References

• ZhuRXSetoWKLaiCLYuenMFEpidemiology of hepatocellular carcinoma in the Asia-Pacific regionGut Liver201610333233927114433
   PubMed Web of Science ®Google Scholar
• FilmusJCapurroMRastJGlypicansGenome Biol20089522418505598
   PubMed Web of Science ®Google Scholar
• TraisterAShiWFilmusJMammalian Notum induces the release of glypicans and other GPI anchored proteins from the cell surfaceBiochem J2008410350351117967162
   PubMed Web of Science ®Google Scholar
• YamauchiNWatanabeAHishinumaMThe glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinomaMod Pathol200518121591159815920546
   PubMed Web of Science ®Google Scholar
• CapurroMIXuPShiWLiFJiaAFilmusJGlypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog bindingDev Cell200814570071118477453
   PubMed Web of Science ®Google Scholar
• ZhangLLiuHSunLLiNDingHZhengJGlypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based studyActa Histochem2012114654755222119409
   PubMed Web of Science ®Google Scholar
• HsuHCChengWLaiPLCloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distributionCancer Res19975722517951849371521
   PubMed Web of Science ®Google Scholar
• CapurroMWanlessIRShermanMGlypican-3: a novel serum and histochemical marker for hepatocellular carcinomaGastroenterology20031251899712851874
   PubMed Web of Science ®Google Scholar
• LiuHLiPZhaiYDiagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinomaWorld J Gastroenterol201016354410441520845507
   PubMed Web of Science ®Google Scholar
• QiaoSSCuiZQGongLSimultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinomaHepatogastroenterology201158110–1111718172421940340
   PubMedGoogle Scholar
• LiBLiuHShangHWLiPLiNDingHGDiagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patientsAfr Health Sci201313370370924250310
   PubMed Web of Science ®Google Scholar
• LiuJWZuoXLWangSDiagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysisEur Rev Med Pharmacol Sci201519193655367326502856
   PubMed Web of Science ®Google Scholar
• ShamJGKievitFMGriersonJRGlypican-3-targeted Zr PET imaging of hepatocellular carcinomaJ Nucl Med201455579980424627434
   PubMed Web of Science ®Google Scholar
• ZhuDQinYWangJNovel Glypican-3-binding peptide for in vivo hepatocellular carcinoma fluorescent imagingBioconjug Chem201627383183926850086
   PubMed Web of Science ®Google Scholar
• FuSJQiCYXiaoWKLiSQPengBGLiangLJGlypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resectionSurgery2013154353654423601901
   PubMed Web of Science ®Google Scholar
• YoritaKTakahashiNTakaiHPrognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinomaLiver Int201131112013120964802
   PubMed Web of Science ®Google Scholar
• ShirakawaHSuzukiHShimomuraMGlypican-3 expression is correlated with poor prognosis in hepatocellular carcinomaCancer Sci200910081403140719496787
   PubMed Web of Science ®Google Scholar
• LiJGaoJZDuJLWeiLXPrognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysisWorld J Gastroenterol201420206336634424876756
   PubMed Web of Science ®Google Scholar
• XiaoWKQiCYChenDPrognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysisBMC Cancer20141410424548704
   PubMed Web of Science ®Google Scholar
• CapurroMIXiangYYLobeCFilmusJGlypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signalingCancer Res200565146245625416024626
   PubMed Web of Science ®Google Scholar
• LiLJinRZhangXOncogenic activation of GPC3 by c-Myc in human hepatocellular carcinomaHepatology20125641380139022706665
   PubMed Web of Science ®Google Scholar
• ZittermannSICapurroMIShiWFilmusJSoluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivoInt J Cancer201012661291130119816934
   PubMed Web of Science ®Google Scholar
• SunCKChuaMSHeJSoSKSuppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2Neoplasia201113873574721847365
   PubMed Web of Science ®Google Scholar
• GauglhoferCSagmeisterSSchrottmaierWUp-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesisHepatology201153385486421319186
   PubMed Web of Science ®Google Scholar
• AcloqueHAdamsMSFishwickKBronner-FraserMNietoMAEpithelial–mesenchymal transitions: the importance of changing cell state in development and diseaseJ Clin Invest200911961438144919487820
   PubMed Web of Science ®Google Scholar
• WuYLiuHWengHGlypican-3 promotes epithelial–mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathwayInt J Oncol20154631275128525572615
   PubMed Web of Science ®Google Scholar
• RuanJLiuFChenXInhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell lineInt J Mol Med201128449750321617840
   PubMed Web of Science ®Google Scholar
• BaumhoerDTornilloLStadlmannSRoncalliMDiamantisEKTerraccianoLMGlypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samplesAm J Clin Pathol2008129689990618480006
   PubMed Web of Science ®Google Scholar
• LlovetJMChenYWurmbachEA molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosisGastroenterology200613161758176717087938
   PubMed Web of Science ®Google Scholar
• ZhuZWFriessHWangLEnhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disordersGut200148455856411247902
   PubMed Web of Science ®Google Scholar
• HoMKimHGlypican-3: a new target for cancer immunotherapyEur J Cancer201147333333821112773
   PubMed Web of Science ®Google Scholar
• FilmusJCapurroMGlypican-3: a marker and a therapeutic target in hepatocellular carcinomaFEBS J2013280102471247623305321
   PubMed Web of Science ®Google Scholar
• NakanoKIshiguroTKonishiHGeneration of a humanized anti-glypican 3 antibody by CDR grafting and stability optimizationAnticancer Drugs2010211090791620847643
   PubMed Web of Science ®Google Scholar
• NakanoKOritaTNezuJAnti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cellsBiochem Biophys Res Commun2009378227928419022220
   PubMed Web of Science ®Google Scholar
• IshiguroTSugimotoMKinoshitaYAnti-glypican 3 antibody as a potential antitumor agent for human liver cancerCancer Res200868239832983819047163
   PubMed Web of Science ®Google Scholar
• ZhuAXGoldPJEl-KhoueiryABFirst-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaClin Cancer Res201319492092823362325
   PubMed Web of Science ®Google Scholar
• YenCJDanieleBKudoMRandomized phase II trial of intravenous RO5137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinomaJ Clin Oncol201432Suppl 5 abstract 4102
   Google Scholar
• FengMHoMGlypican-3 antibodies: a new therapeutic target for liver cancerFEBS Lett2014588237738224140348
   PubMed Web of Science ®Google Scholar
• GaoWTangZZhangYFImmunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesisNat Commun20151166536
   Web of Science ®Google Scholar
• GaoHLiKTuHDevelopment of T cells redirected to glypican-3 for the treatment of hepatocellular carcinomaClin Cancer Res201420246418642825320357
   PubMed Web of Science ®Google Scholar